JP2010514842A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514842A5
JP2010514842A5 JP2009544958A JP2009544958A JP2010514842A5 JP 2010514842 A5 JP2010514842 A5 JP 2010514842A5 JP 2009544958 A JP2009544958 A JP 2009544958A JP 2009544958 A JP2009544958 A JP 2009544958A JP 2010514842 A5 JP2010514842 A5 JP 2010514842A5
Authority
JP
Japan
Prior art keywords
benzamide
benzyl
tetrahydro
dimethoxy
ylcarbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009544958A
Other languages
English (en)
Japanese (ja)
Other versions
JP5258790B2 (ja
JP2010514842A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/050014 external-priority patent/WO2008086047A1/en
Publication of JP2010514842A publication Critical patent/JP2010514842A/ja
Publication of JP2010514842A5 publication Critical patent/JP2010514842A5/ja
Application granted granted Critical
Publication of JP5258790B2 publication Critical patent/JP5258790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009544958A 2007-01-03 2008-01-02 Rhoキナーゼインヒビター Expired - Fee Related JP5258790B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87862507P 2007-01-03 2007-01-03
US60/878,625 2007-01-03
PCT/US2008/050014 WO2008086047A1 (en) 2007-01-03 2008-01-02 Rho kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2010514842A JP2010514842A (ja) 2010-05-06
JP2010514842A5 true JP2010514842A5 (https=) 2011-02-24
JP5258790B2 JP5258790B2 (ja) 2013-08-07

Family

ID=39313484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009544958A Expired - Fee Related JP5258790B2 (ja) 2007-01-03 2008-01-02 Rhoキナーゼインヒビター

Country Status (8)

Country Link
US (1) US8093266B2 (https=)
EP (1) EP2114869B1 (https=)
JP (1) JP5258790B2 (https=)
AR (1) AR064726A1 (https=)
CA (1) CA2674389A1 (https=)
CL (1) CL2007003874A1 (https=)
TW (1) TW200843770A (https=)
WO (1) WO2008086047A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721333D0 (en) * 2007-10-31 2007-12-12 Motac Neuroscience Ltd Medicaments
WO2010024258A1 (ja) * 2008-08-29 2010-03-04 塩野義製薬株式会社 Pi3k阻害活性を有する縮環アゾール誘導体
WO2011011514A1 (en) * 2009-07-21 2011-01-27 The Board Of Trustees Of The Leland Stanford Junior University Heteroaryl benzamides, compositions and methods of use
WO2011062765A2 (en) 2009-11-17 2011-05-26 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
EP2531490B1 (en) * 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
US9079880B2 (en) 2010-07-07 2015-07-14 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US8697911B2 (en) 2010-07-07 2014-04-15 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
EP2630144B1 (en) 2010-10-19 2016-09-07 Boehringer Ingelheim International GmbH Rho kinase inhibitors
AU2011329233A1 (en) 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
US9029370B2 (en) 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
US8921576B2 (en) 2011-10-19 2014-12-30 Kowa Company, Ltd. Spiroindoline compound, and medicinal agent comprising same
CN104011026B (zh) 2011-12-20 2016-07-20 拜耳知识产权股份有限公司 杀虫用芳酰胺
AU2013318206B2 (en) 2012-09-20 2018-07-26 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
JP6488239B2 (ja) 2013-01-18 2019-03-20 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Rock阻害剤としてのフタラジノンおよびイソキノリノン
WO2014177699A1 (en) * 2013-05-03 2014-11-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease
US9902702B2 (en) 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
WO2016028971A1 (en) 2014-08-21 2016-02-25 Bristol-Myers Squibb Company Tied-back benzamide derivatives as potent rock inhibitors
WO2016180918A1 (en) 2015-05-12 2016-11-17 Platod Combination of pharmacological and microfluidic features for improved platelets production
KR20180011843A (ko) 2015-06-11 2018-02-02 바실리어 파마슈티카 인터내셔널 리미티드 유출-펌프 억제제 및 이의 치료적 용도
CN105195114B (zh) * 2015-10-29 2017-08-25 重庆郑博生物科技有限公司 脓毒症多种致病因子的吸附材料及其制备方法和用途
TWI730032B (zh) 2016-01-13 2021-06-11 美商必治妥美雅史谷比公司 作為rock抑制劑之螺庚烷水楊酸醯胺及相關化合物
ES2829550T3 (es) 2016-07-07 2021-06-01 Bristol Myers Squibb Co Ureas cíclicas espiro-condensadas como inhibidores de ROCK
CN108203433B (zh) * 2016-12-16 2020-07-03 成都先导药物开发股份有限公司 一种rock抑制剂及其应用
TW201908293A (zh) 2017-07-12 2019-03-01 美商必治妥美雅史谷比公司 作為rock抑制劑之5員及雙環雜環醯胺
JP7234201B2 (ja) 2017-07-12 2023-03-07 ブリストル-マイヤーズ スクイブ カンパニー 心不全の治療のためのrockの5員アミノヘテロ環および5,6-または6,6員二環式アミノヘテロ環の阻害剤
US11447487B2 (en) 2017-07-12 2022-09-20 Bristol-Myers Squibb Company Spiroheptanyl hydantoins as rock inhibitors
US11306081B2 (en) 2017-07-12 2022-04-19 Bristol-Myers Squibb Company Phenylacetamides as inhibitors of rock
EP3843845B1 (en) 2018-08-29 2026-03-11 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
WO2023091565A1 (en) * 2021-11-17 2023-05-25 The University Of North Carolina At Chapel Hill Nsd2-targeted chemical degraders and compositions and methods of use thereof
WO2024076155A1 (ko) * 2022-10-04 2024-04-11 노보렉스 주식회사 Yeats 도메인 억제제로서 신규한 화합물
WO2025240834A1 (en) * 2024-05-17 2025-11-20 The University Of North Carolina At Chapel Hill Nsd2-targeted chemical degraders and compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0952832B1 (en) * 1996-05-20 2008-08-27 Darwin Discovery Limited Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
JPH11139969A (ja) * 1997-08-07 1999-05-25 Tanabe Seiyaku Co Ltd 医薬組成物
JPH11130751A (ja) 1997-10-30 1999-05-18 Yoshitomi Pharmaceut Ind Ltd アミド化合物およびそれらの酸付加塩の標識化合物
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Rhoキナーゼ阻害剤
DE10357510A1 (de) * 2003-12-09 2005-07-07 Bayer Healthcare Ag Heteroarylsubstituierte Benzole
WO2005074643A2 (en) * 2004-01-30 2005-08-18 Smithkline Beecham Corporation Benzamide compounds useful as rock inhibitors

Similar Documents

Publication Publication Date Title
JP2010514842A5 (https=)
JP5258790B2 (ja) Rhoキナーゼインヒビター
JP6511430B2 (ja) がんの治療のための化合物および組成物
AU2002226674B2 (en) Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
KR101721025B1 (ko) 테트라하이드로벤조티오펜 화합물
JP2012502986A5 (https=)
KR20090127307A (ko) 히스타민 h3 수용체 조절제로서의 테트라하이드로이소퀴놀린 화합물
JP2007521287A5 (https=)
RU2019136536A (ru) Ингибиторы гистондеацетилаз (hdac)
CA2578955A1 (en) Isoindolin-1-one derivatives
RU2007146462A (ru) Диарилгидантоины
AU2004272437A1 (en) CRF antagonists and heterobicyclic compounds
AU2008214372A1 (en) Therapeutic agents
JP2005514398A5 (https=)
JP2009523812A5 (https=)
WO2011019738A1 (en) Compounds and methods of use thereof
CN108884061A (zh) 1,2,4-三嗪-3-胺类衍生物、其制备方法及其在医药上的应用
JPH11171865A (ja) 縮合ヘテロ環化合物
IL269144B1 (en) Pyrrolotriazine derivatives as kinase inhibitors
JPH0641471B2 (ja) チエノトリアゾロジアゼピン化合物およびその医薬用途
AU2020298779A1 (en) Estrogen-related receptor alpha (ERRα) modulators
WO2008124524A2 (en) Aryl sulfonamide compounds as modulators of the cck2 receptor
JP2017119628A (ja) 置換アゾール化合物及び糖尿病治療薬
JPWO2016021706A1 (ja) 縮合複素環化合物
CN113754649B (zh) 一类含二唑、三唑及吡唑结构单元的吲哚衍生物及其应用